US 8101567
Heteroaryl-containing tripeptide HCV serine protease inhibitors
granted A61KA61K31/4965A61K38/21
Quick answer
US patent 8101567 (Heteroaryl-containing tripeptide HCV serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4965, A61K38/21, A61P, A61P1/16